Insperity Q4 Revenue of $1.67B Misses Expectations, Adjusted EBITDA Falls to -$13M
Insperity posted Q4 CY2025 revenue of $1.67B (+3.4% yoy) versus $1.68B expected, and an adjusted loss of $0.60/share, missing the $0.47 consensus, while adjusted EBITDA slid to -$13M (-0.8% margin). Management targets 2026 margin recovery through repricing, cost cuts and early HRScale rollout.
1. Q4 CY2025 Financial Results
Insperity recorded revenue of $1.67 billion in Q4 CY2025, representing a 3.4% year-on-year increase but missing the $1.68 billion estimate. The company reported an adjusted loss of $0.60 per share versus the $0.47 consensus and negative adjusted EBITDA of $13 million (-0.8% margin).
2. Performance Challenges and Cost Actions
Management attributed the quarterly shortfall to weak client net hiring and elevated healthcare claims costs, which squeezed gross margins. To stabilize profitability, Insperity consolidated sales offices and realigned approximately 4% of non-sales staff, aiming for $20 million in annual savings alongside price increases in the teens.
3. 2026 Outlook and HRScale Launch
For fiscal 2026, Insperity guided to $2.21 adjusted EPS at midpoint and $200 million adjusted EBITDA, both below analyst forecasts. Margin recovery is central to the plan, driven by repricing efforts, cost containment and the early rollout of HRScale, its new mid-market HR platform developed with Workday.